|Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy|
A Kambugu, DB Meya, J Rhein, M O'Brien, EN Janoff, AR Ronald, ...
Clinical infectious diseases 46 (11), 1694-1701, 2008
|Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis|
DR Boulware, DB Meya, C Muzoora, MA Rolfes, K Huppler Hullsiek, ...
New England Journal of Medicine 370 (26), 2487-2498, 2014
|Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions|
EH Geng, D Nash, A Kambugu, Y Zhang, P Braitstein, KA Christopoulos, ...
Current HIV/AIDS Reports 7 (4), 234-244, 2010
|Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start …|
DB Meya, YC Manabe, B Castelnuovo, BA Cook, AM Elbireer, ...
Clinical Infectious Diseases 51 (4), 448-455, 2010
|Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study|
DR Boulware, DB Meya, TL Bergemann, DL Wiesner, J Rhein, ...
PLoS medicine 7 (12), e1000384, 2010
|Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy|
MR Kamya, H Mayanja-Kizza, A Kambugu, S Bakeera-Kitaka, F Semitala, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (2), 187-193, 2007
|Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome|
DR Boulware, SC Bonham, DB Meya, DL Wiesner, GS Park, A Kambugu, ...
The Journal of infectious diseases 202 (6), 962-970, 2010
|Assessment of second-line antiretroviral regimens for HIV therapy in Africa|
NI Paton, C Kityo, A Hoppe, A Reid, A Kambugu, A Lugemwa, ...
New England Journal of Medicine 371 (3), 234-247, 2014
|Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy|
A Reid, W Stöhr, AS Walker, IG Williams, C Kityo, P Hughes, A Kambugu, ...
Clinical infectious diseases 46 (8), 1271-1281, 2008
|Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources|
R Colebunders, L John, V Huyst, A Kambugu, F Scano, L Lynen
The International Journal of Tuberculosis and Lung Disease 10 (9), 946-953, 2006
|Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort|
B Castelnuovo, YC Manabe, A Kiragga, M Kamya, P Easterbrook, ...
Clinical Infectious Diseases 49 (6), 965-972, 2009
|Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda|
J Wanyama, B Castelnuovo, B Wandera, P Mwebaze, A Kambugu, ...
Aids 21 (11), 1486-1487, 2007
|Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa|
SM Hermans, AN Kiragga, P Schaefer, A Kambugu, AIM Hoepelman, ...
PloS one 5 (5), e10527, 2010
|Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis|
DL Wiesner, O Moskalenko, JM Corcoran, T McDonald, MA Rolfes, ...
MBio 3 (5), e00196-12, 2012
|Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort study|
EH Geng, TA Odeny, RE Lyamuya, A Nakiwogga-Muwanga, L Diero, ...
The lancet HIV 2 (3), e107-e116, 2015
|Implementation of provider-based electronic medical records and improvement of the quality of data in a large HIV program in Sub-Saharan Africa|
B Castelnuovo, A Kiragga, V Afayo, M Ncube, R Orama, S Magero, ...
PloS one 7 (12), e51631, 2012
|Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: application …|
EH Geng, TA Odeny, R Lyamuya, A Nakiwogga-Muwanga, L Diero, ...
Clinical Infectious Diseases 62 (7), 935-944, 2015
|Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa|
ML Petersen, L Tran, EH Geng, SJ Reynolds, A Kambugu, R Wood, ...
AIDS (London, England) 28 (14), 2097, 2014
|HIV serostatus disclosure and lived experiences of adolescents at the Transition Clinic of the Infectious Diseases Clinic in Kampala, Uganda: a qualitative study|
GE Siu, S Bakeera-Kitaka, CE Kennedy, A Dhabangi, A Kambugu
AIDS care 24 (5), 606-611, 2012
|Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda|
JB Babigumira, B Castelnuovo, M Lamorde, A Kambugu, A Stergachis, ...
BMC Health Services Research 9 (1), 192, 2009